Back to search
FDAFDA · Food and drugs·Recall number D-0581-2026

Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696-02 (vial), NDC 63323-696-25 (carton)

Published June 17, 2026 · Recall initiated: May 14, 2026

Summary

FDA records drug Class III recall D-0581-2026, published June 17, 2026 and initiated May 14, 2026. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 898,050 vials; Lot: Batch # 6133313, 6133314, Exp Date: 06/2026; Batch # 6133315, Exp Date: 07/2026; Batch # 6133682, Exp Date: 09/2026; Batch # 6134812, 6134813, Exp Date: 04/2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradations Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if EPINEPHRINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EPINEPHRINE
Manufacturer
Fresenius Kabi USA, LLC
Distributor
US Nationwide.
UPC
0363323696023
Lot
Batch # 6133313, 6133314, Exp Date: 06/2026; Batch # 6133315, Exp Date: 07/2026; Batch # 6133682, Exp Date: 09/2026; Batch # 6134812, 6134813, Exp Date: 04/2027.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Epinephrine Injection, USP, 1mg/mL, 1 mL single-dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-696-02 (vial), NDC 63323-696-25 (carton) recalled?

Yes. FDA published recall D-0581-2026 on June 17, 2026. Reported hazard: Failed Impurities/Degradations Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EPINEPHRINE. UPC: 0363323696023.